 - Post-transplant graft-versus-host disease GVHD prophylaxis: Patients who undergo cord blood SCT receive cyclosporine and methylprednisolone for graft-versus-host disease GVHD prophylaxis. Patients who undergo peripheral blood or bone marrow SCT receive cyclosporine and methotrexate short course for GVHD prophylaxis. 